Skip to main content
Inicio
language-selector-globe Mexico | es
Selecciona localización
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Mexico
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Novartis México 
      • Novartis en México 
      • Nuestra Estrategia 
      • Cultura y Asociados 
      • Equipo Directivo 
      • Contáctanos 
      Profesionales en laboratorio Novartis México
    • Nuestro Compromiso con México 
      • Impacto en México 
      • Financiamiento Externo 
      • Ética, Riesgo y Cumplimiento 
      • Acceso 
      • Sostenibilidad Ambiental 
      • Salud Global 
      Paciente y profesional de la salud tomándose las manos Nuestro Compromiso con México
    • Sala de Prensa 
      • Contacto para Prensa 
      Profesional trabajando en laboratorio Sala de Prensa
    • Somos el Lugar para Crecer 
      • Oportunidades Laborales 
      • Nuestra Propuesta de Valor 
      • Nuestra Forma de Trabajo 
      • Bienestar 
      • Diversidad e Inclusión (D&I) 
      • Programas de Atracción de Talento 
      • Rankings y Certificaciones 
      Personas hablando en una sala de juntas Somos el Lugar para Crecer
    Imagen panorámica de campo de agave en México Inicio
  1. Inicio
  2. Somos el Lugar para Crecer
  3. Oportunidades Laborales
  • Sort by Sort ascending
  • Título profesional
  • Sitio
  • Ubicación
  • División
  • Negocio Sort ascending
  • Functional Area
  • Fecha de publicación
Título profesional Sitio Ubicación División Negocio Sort ascending Functional Area Fecha de publicación
Business Data Migration Lead INSURGENTES México Operations CTS BD&L & Strategic Planning Oct 23, 2024
Record to Report Sr. Specialist USA INSURGENTES México Finance CTS Auditoría y Finanzas Oct 23, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Márketing May 20, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES México Finance CTS Auditoría y Finanzas Jul 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES México Finance CTS Auditoría y Finanzas Aug 06, 2024
LDC Adopt Process Lead - Taxes INSURGENTES México Operations CTS Auditoría y Finanzas Aug 19, 2024
TCM Senior Cash Management Specialist INSURGENTES México Operations CTS Auditoría y Finanzas Aug 30, 2024
Record to Report Specialist INSURGENTES México Finance CTS Auditoría y Finanzas Sep 05, 2024
Record to Report Sr Specialist INSURGENTES México Operations CTS Auditoría y Finanzas Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES México Operations CTS Auditoría y Finanzas Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES México Operations CTS Auditoría y Finanzas Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES México Operations CTS Auditoría y Finanzas Sep 10, 2024
Buyer LACan (Temporary) INSURGENTES México Operations CTS Obtención Sep 15, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japón Finance CTS Auditoría y Finanzas Jun 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japón Operations CTS Tecnologías de la información Jul 22, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Márketing May 20, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Auditoría y Finanzas Jun 20, 2024
Corporate Tax Manager Amiria Egipto Finance Corporate Auditoría y Finanzas May 31, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malasia Ethics Risk & Compliance Corporate Propiedad legal e intelectual y cumplimiento Aug 29, 2024
Manager- Data Privacy Review and Remediation Selangor Malasia Ethics Risk & Compliance Corporate Propiedad legal e intelectual y cumplimiento Oct 14, 2024
Associate Director, Political Affairs & Insights Washington, DC Estados Unidos Corporate Affairs Corporate Communications & Public Affairs Oct 22, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía España Finance Corporate Auditoría y Finanzas Oct 22, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Auditoría y Finanzas Sep 17, 2024
Associate Director, SUSE Linux Administrator Prague República Checa Operations Corporate Technology Transformation Sep 23, 2024
Associate Director, US Federal and State Tax Reporting East Hanover Estados Unidos Finance Corporate Auditoría y Finanzas Sep 06, 2024
Expert Analyst – Management Reporting Prague República Checa Finance Corporate Auditoría y Finanzas Oct 08, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Suiza Legal Corporate Others Sep 26, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Alemania Finance Corporate Auditoría y Finanzas Oct 16, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) Estados Unidos Legal Corporate Propiedad legal e intelectual y cumplimiento Oct 17, 2024
Executive Director, R&D Legal and FDA Regulatory Legal Lead East Hanover Estados Unidos Legal Corporate Propiedad legal e intelectual y cumplimiento Oct 17, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Auditoría y Finanzas Aug 29, 2024
Associate Director, M&A Planning & Integration East Hanover Estados Unidos Finance Corporate Auditoría y Finanzas Oct 17, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Suiza Corporate Affairs Corporate BD&L & Strategic Planning Oct 15, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Auditoría y Finanzas Oct 24, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Reino Unido Finance Corporate Auditoría y Finanzas Oct 25, 2024
Financial IT Compliance Manager London (The Westworks) Reino Unido Finance Corporate Auditoría y Finanzas Oct 25, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Business Data Analyst II Hyderabad (Office) India Biomedical Research Data and Digital Sep 11, 2024
BR Submission Management, Lead Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
BR Submission Management, Specialist Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
Clinical Data Specialist II Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist I Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Senior Specialist - Automation Engineer Sasayama Japón Operations Research & Development Jul 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis México

Conoce Novartis
  • Nuestro Compromiso con México
  • Sala de Prensa
  • Somos el Lugar para Crecer
Nuestro Compromiso
  • Impacto en México
  • Acceso
  • Sostenibilidad Ambiental
Talento
  • Oportunidades Laborales
  • Nuestra forma de Trabajo
  • Diversidad e Inclusión (D&I)
  • Programas de Atracción de Talento
Footer Bottom
© 2024 Novartis MX
  • Aviso de Privacidad
  • Condiciones de uso
  • Configuración de cookies
  • Mapa del sitio
  • Accesibilidad
Directorio de Novartis
Sitio dirigido a audiencia local.
COFEPRIS Permiso de Publicidad: 233300201B1273
Consulte a su médico